PharmaEssentia company profile

6446 · TWSE · TWD

Compare PharmaEssentia
$1,100.00Change from previous close: −8.71%Absolute change: −$105.00

Close · November 20, 2026

Company profile

PharmaEssentia has 131 employees and is headquartered in Taipei, Taiwan.

With revenue of TWD 15.6 billion in the fiscal year ended December 2025, PharmaEssentia Corporation develops specialty pharmaceutical reagents, active pharmaceutical ingredients and new drugs, with activities in the Americas, Europe, Asia and Taiwan. Its main product, BESREMi, is used to treat polycythemia vera and essential thrombocythemia, and the company also works on treatments for adult T-cell leukemia. Its pipeline spans cancer and immunology programs, including PEG-IL-2, PD-1-IL-2v and TCR-T therapies for solid tumors.

Revenue rose 60.6% from the previous year, and net income for the same fiscal year reached TWD 5.0 billion. The company employs 131 people. Founded in 1990, it is headquartered in Taipei, Taiwan.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
Taiwan
Headquarters
No. 3, Park Street, 115, Taipei
Employees
131
Chief executive
Ko-Chung Lin
Founded
1990
Fiscal year
January - December
Listing
6446 · TWSE
Currency
TWD
ISIN
TW0006446008

PharmaEssentia and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
PharmaEssentia6446Taiwan$15.94B13138.4%74.1
Shionogi4507Japan$16.75B6,22331.6%11.2
Yunnan Baiyao Group000538China$15.07B9,28611.2%19.4
Laurus LabsLAURUSLABSIndia$14.13B7,05924.1%97.8
Torrent PharmaceuticalsTORNTPHARMIndia$19.25B18,25822.2%79.2
Zydus LifesciencesZYDUSLIFEIndia$12.92B29,98017.2%28.7

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare PharmaEssentia with its competitors